When analysts say sell, it’s time to buy – at least in biotech, new report shows

A new analysis finds that investors would be better off ignoring – or even doing the exact opposite of – the advice of equity analysts. The worse a stock’s rating, the better its performance, on average, in the following year, a new report from Cowen Research shows.